Apothecure, Inc.

Form 483 issued April 16, 2013 · Dallas, Texas

Inspection
Mar 18 – Apr 16, 2013
Observations
13
Pages
16
FEI number
3000203232

In short: On April 16, 2013, FDA issued a Form 483 with 13 observations to Apothecure, Inc. in Dallas, Texas (FEI 3000203232) after an inspection that ran Mar 18 – Apr 16, 2013. The investigators were Jamillah Selby, John T. Chapman and Stephen D. Brown. Most observations concern production and laboratory controls; the most-cited regulation is 21 CFR 211.42 (design and construction features).

At a glance

Observations span 4 systems, led by production.

Production4
Laboratory controls3
Facilities & equipment3
Quality system2
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review the failure of a batch or any of its…

  2. 02

    Procedures designed to prevent microbiological contamination ofdrug products purporting to be sterile are not…

  3. 03

    There is no written testing program designed to assess the stability…

  4. 04

    Procedures describing the handling of all written and oral complaints regarding a drug…

9 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Apothecure, Inc.?

FDA listed 13 observations on this Form 483, mostly about production, laboratory controls and facilities & equipment. The most-cited regulation is 21 CFR 211.42 (design and construction features). The opening words of each observation are shown on this page.

Who inspected Apothecure, Inc.?

Jamillah Selby, John T. Chapman and Stephen D. Brown are named on this Form 483, for the inspection of Mar 18 – Apr 16, 2013. Each investigator has a profile showing what they cite most.

When was Apothecure, Inc. inspected by FDA?

The inspection ran Mar 18 – Apr 16, 2013, and the Form 483 is dated April 16, 2013.

How do I get the full Form 483 for Apothecure, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free